Outpatient treatment for haemophilic arthropathy with radiosynovectomy: Radiation dose to family members
- 13 March 2019
- journal article
- research article
- Published by Wiley in Haemophilia
- Vol. 25 (3) , 509-513
Abstract
One of the key features of good practice in medicine is the doctor‐patient communication. Radiation protection standards for radiosynovectomy (RS) is limited. Yttrium‐90 is a beta‐emitting radioisotope used in RS to treat joint pain from haemophilic arthritis. ICRP 94 states that if a patient is treated with up to 200 MBq, there is no need for further precautions when it comes to public exposure, however, activities can go up to 370 MBq in RS for the knee. This study analysed 119 family members’ safety (16.7% pregnant women). The ambient dose equivalent rate was measured within four distances. A survey was carried analysing risk groups and time spent next to patients. Results showed that family members should be advised to remain at 1.0 m from the patient to decrease accumulated dose by 97.6%. The dose per activity factors estimated in this study is also a useful tool during the risk assessment and doctor/patient communication. Pamphlets were distributed with radiation protection recommendations. Ambient dose equivalent was low enough to show that RS is a safe procedure for family members, which is essential to promote adherence to RS in countries where it is needed but not performed due to lack of information on radiation safety.Keywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
This publication has 21 references indexed in Scilit:
- Evaluation of Hepatic Tumor Response to Yttrium-90 Radioembolization Therapy Using Texture Signatures Generated from Contrast-enhanced CT ImagesAcademic Radiology, 2012
- Guidelines for the management of hemophiliaHaemophilia, 2012
- Radiation Safety in the Treatment of Patients with Thyroid Diseases by Radioiodine 131 I: Practice Recommendations of the American Thyroid AssociationThyroid®, 2011
- 90Yttrium‐hydroxyapatite: a new therapeutic option for radioactive synovectomy in haemophilic synovitisHaemophilia, 2011
- Radiation Safety Issues in Y-90 Microsphere Selective Hepatic Radioembolization Therapy: Possible Radiation Exposure from the PatientsNuclear Medicine and Molecular Imaging, 2010
- Radioactive synovectomy with Yttrium90citrate in haemophilic synovitis: Brazilian experienceHaemophilia, 2010
- The role of synovectomy in the management of a target jointHaemophilia, 2008
- Radiation protection in radionuclide therapies with 90Y-conjugates: risks and safetyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2006
- EANM Procedure Guidelines for RadiosynovectomyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003
- Aktivitätsabtransport und Strahlenexposition durch die Radiosynoviorthese des Kniegelenkes: Einfluß unterschiedlicher TherapiemodalitätenZeitschrift für Rheumatologie, 1999